List of XiFin Empower RCM Customers
San Diego, 92130, CA,
United States
Since 2010, our global team of researchers has been studying XiFin Empower RCM customers around the world, aggregating massive amounts of data points that form the basis of our forecast assumptions and perhaps the rise and fall of certain vendors and their products on a quarterly basis.
Each quarter our research team identifies companies that have purchased XiFin Empower RCM for Revenue Cycle Management from public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources, including the customer size, industry, location, implementation status, partner involvement, LOB Key Stakeholders and related IT decision-makers contact details.
Companies using XiFin Empower RCM for Revenue Cycle Management include: Clinical Pathology Laboratories, a United States based Professional Services organisation with 2300 employees and revenues of $800.0 million, Caris Life Sciences, a United States based Healthcare organisation with 1500 employees and revenues of $400.0 million, Sonora Quest Laboratories, a United States based Healthcare organisation with 3700 employees and revenues of $310.0 million and many others.
Contact us if you need a completed and verified list of companies using XiFin Empower RCM, including the breakdown by industry (21 Verticals), Geography (Region, Country, State, City), Company Size (Revenue, Employees, Asset) and related IT Decision Makers, Key Stakeholders, business and technology executives responsible for the software purchases.
The XiFin Empower RCM customer wins are being incorporated in our Enterprise Applications Buyer Insight and Technographics Customer Database which has over 100 data fields that detail company usage of software systems and their digital transformation initiatives. Apps Run The World wants to become your No. 1 technographic data source!
Apply Filters For Customers
| Logo | Customer | Industry | Empl. | Revenue | Country | Vendor | Application | Category | When | SI | Insight | Insight Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Caris Life Sciences | Healthcare | 1500 | $400M | United States | XIFIN | XiFin Empower RCM | Revenue Cycle Management | 2024 | n/a | In 2024, Caris Life Sciences contracted with XIFIN and went live on XiFin Empower RCM for enterprise Revenue Cycle Management across its precision medicine operations in the United States. The engagement established XiFin Empower RCM as the platform for centralizing billing and revenue workflows, and XIFIN stated the 2024 go-live provided Caris scalable, compliant RCM with improved visibility and control over revenue operations. XiFin Empower RCM was implemented with explicit use of the RCM and billing modules, aligning core Revenue Cycle Management capabilities such as billing workflow automation, claims lifecycle orchestration, payer rules configuration, and revenue operations reporting. Configuration emphasis targeted billing rules and operational dashboards to provide finance and billing teams with consolidated visibility into account receivables and revenue status. Operational coverage focused on enterprise revenue cycle management across Caris' precision medicine business units in the United States, with deployment and governance oriented toward centralized billing control and compliance oversight. The rollout chronology reflected a contracted go-live in 2024 and a governance posture that prioritized standardized billing workflows and enhanced operational control as stated by XIFIN. | |
|
|
Clinical Pathology Laboratories | Professional Services | 2300 | $800M | United States | XIFIN | XiFin Empower RCM | Revenue Cycle Management | 2024 | n/a | In 2024, Clinical Pathology Laboratories implemented XiFin Empower RCM to centralize laboratory billing and Revenue Cycle Management for multiple Sonic Healthcare USA divisions in the United States. The deployment of XiFin Empower RCM was Sonic’s third division to move onto XiFin Empower, and the effort focused on consolidating billing operations and establishing a single RCM platform for clinical laboratory revenue processes. Configuration emphasized billing and core RCM modules, with explicit use of billing/RCM capabilities aligned to standard Revenue Cycle Management workflows such as claims submission, payer management workflows, denial handling, and patient balance posting. Operational scope covered laboratory billing, collections, and payor management across Sonic divisions, and the implementation was positioned to standardize governance, streamline collections processes, and centralize operational controls as part of a phased rollout across laboratory operations. | |
|
|
Sonora Quest Laboratories | Healthcare | 3700 | $310M | United States | XIFIN | XiFin Empower RCM | Revenue Cycle Management | 2008 | n/a | In 2008, Sonora Quest Laboratories implemented XiFin Empower RCM to manage laboratory billing and claims processing across the United States. Sonora Quest Laboratories deployed XiFin Empower RCM as its Revenue Cycle Management platform to centralize billing workflows and support enterprise billing operations for clinical laboratory services. The deployment explicitly included XiFin RPM/RCM and an insurance discovery integration as core functional components. Integration with FrontRunnerHC was incorporated to enhance insurance discovery and payer data matching, aligning claims submission and adjudication workflows with the XiFin Empower RCM processing engine. XiFin's published success story credited the Sonora Quest deployment with reducing days-sales-outstanding by more than 10 days and saving over $1M annually. Operational coverage focused on laboratory billing and claims processing, impacting revenue operations and billing departments across Sonora Quest Laboratories in the United States. |
Buyer Intent: Companies Evaluating XiFin Empower RCM
Discover Software Buyers actively Evaluating Enterprise Applications
| Logo | Company | Industry | Employees | Revenue | Country | Evaluated | ||
|---|---|---|---|---|---|---|---|---|
| No data found | ||||||||